Global Health (MEDANTA) Share Price Falls 2.52% as MEDANTA Slips to Rs 1,431.90

MEDANTA Share Price fell to Rs 1,431.90 on 07 September 2026 at 11:23:24 AM IST, down 2.52% or Rs 36.95 from the previous close of Rs 1,468.85. Global Health opened at Rs 1,478.95, which was also the day’s high, and later moved down to an intraday low of Rs 1,430. The move places the company’s market capitalisation at Rs 39,493.23 crore.

For investors tracking Global Health, the supplied data confirms the price decline but does not identify a company-specific trigger. That means the most reliable way to assess the move is through verified numbers: intraday price behaviour, valuation ratios, profitability metrics, moving-average positioning, and comparison with the broader Hospital & Healthcare Services industry.

Global Health is classified as a Large Cap company in the Healthcare sector. Because of that scale, any notable down move often draws attention not just from company watchers but also from investors screening larger listed hospital names. In this article, the focus stays on what the dataset actually shows rather than on unverified reasons.

Global Health (MEDANTA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,431.9
Previous Close	Rs 1,468.85
Today's Move	-Rs 36.95 (-2.52%)
Open	Rs 1,478.95
High	Rs 1,478.95
Low	Rs 1,430
Turnover	Rs 1.08 crore
Market Capitalisation	Rs 39,493.23 crore
Market Cap Category	Large Cap

On pure price action, the session was weak. The stock opened at Rs 1,478.95 and did not improve beyond that level, making the open and the high identical. From there it moved steadily lower and touched Rs 1,430. With the traded price at Rs 1,431.90, the stock stayed close to the lower end of the day’s range.

That pattern matters because it shows selling pressure after the open rather than a late-session dip from otherwise stable trading. The turnover of Rs 1.08 crore confirms activity, although the data does not indicate who drove the move or whether there was any specific announcement attached to it.

From a technical reference-point view, the stock is near its 50-day moving average of Rs 1,437.69 and remains above its 200-day moving average of Rs 1,241.98. The RSI is 60.65. In simple terms, the supplied numbers show a stock that has slipped below its shorter-term average but is still trading above its longer-term average. For readers checking MEDANTA Share Price Today, that creates a mixed picture rather than a one-directional technical conclusion.

Global Health (MEDANTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 39,493.23 crore
P/E Ratio	71.01x
P/B Ratio	9.61x
ROE	15.12%
ROCE	19.38%
EPS	Rs 20.69
Book Value Per Share	Rs 152.92
Dividend Yield	0.03%

The fundamental snapshot explains why MEDANTA Share Price remains in focus even on a single-session decline. Global Health trades at a P/E ratio of 71.01 and a P/B ratio of 9.61, which indicates that the market is assigning a premium valuation to the business. On their own, such multiples do not say whether the stock is cheap or expensive; they become meaningful only when compared with sector norms and listed peers.

Profitability is firmer than many companies would show at these valuations. ROE stands at 15.12% and ROCE at 19.38%, suggesting solid return generation on both equity and capital employed. EPS is Rs 20.69, while book value per share is Rs 152.92. The dividend yield is only 0.03%, so the supplied dataset points more toward valuation and return metrics than toward income appeal.

For investors following MEDANTA Share Price, the central question is not whether the company has scale or profitability; the numbers confirm both. The main question is how much premium the market is willing to maintain relative to other healthcare service names.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	71.01x
Benchmark Median P/E	46.45x
Benchmark Average P/E	101.64x
Benchmark P/E Range	7.87x to 1,488.32x
Company P/B Ratio	9.61x
Benchmark Median P/B	3.35x
Benchmark Average P/B	4.2x
Company ROE	15.12%
Benchmark Median ROE	12.77%
Benchmark Average ROE	13.51%
Company ROCE	19.38%
Benchmark Median ROCE	15.34%
Benchmark Average ROCE	3.27%
Company Market Capitalisation	Rs 39,493.23 crore
Benchmark Median Market Cap	Rs 519.09 crore
Benchmark Average Market Cap	Rs 11,295.38 crore

The industry comparison set covers 66 companies in the same segment. Against that group, Global Health’s P/E of 71.01 is above the median of 46.45 but below the average of 101.64. Its P/B of 9.61 is well above the median of 3.35 and the average of 4.2. That means the stock sits on the richer side of the valuation spectrum within its own industry.

Profitability, however, compares more favorably. ROE of 15.12% is above the industry median of 12.77% and average of 13.51%. ROCE of 19.38% is also above the median of 15.34% and above the supplied industry average of 3.27%. In market-cap terms, Global Health at Rs 39,493.23 crore is far above the industry median of Rs 519.09 crore and above the average of Rs 11,295.38 crore.

This benchmark view helps frame the current MEDANTA Share Price move. The data shows a business with above-median scale and return ratios, but also one that trades at valuation multiples higher than the typical company in the same industry.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,24,661.3	59.66	12.87	23.54	21.73
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	95,989.65	107.57	5.26	12.95	13.93
Max Healthcare Institute	MAXHEALTH	95,871.06	65.8	8.77	14.53	14.97
Fortis Healthcare	FORTIS	68,701.19	65.56	6.76	11.32	14.07
Aster DM Healthcare	ASTERDM	68,496.02	214.94	13.79	9.32	11.46

Among named peers, Global Health is smaller than Apollo Hospitals Enterprise, MANIPAL HEALTH ENTERPRI L, Max Healthcare Institute, Fortis Healthcare and Aster DM Healthcare on market capitalisation. Even so, it remains a sizeable listed player with a market cap of Rs 39,493.23 crore.

Its P/E of 71.01 is higher than Apollo’s 59.66, Max’s 65.8 and Fortis’s 65.56, but below MANIPAL HEALTH ENTERPRI L at 107.57 and Aster DM Healthcare at 214.94. Its P/B of 9.61 is below Apollo’s 12.87 and Aster’s 13.79, but above Max’s 8.77, Fortis’s 6.76 and MANIPAL HEALTH ENTERPRI L’s 5.26.

On profitability, Global Health’s ROE of 15.12% is above MANIPAL HEALTH ENTERPRI L, Fortis and Aster, slightly above Max, and below Apollo. ROCE of 19.38% is above MANIPAL HEALTH ENTERPRI L, Max, Fortis and Aster, though below Apollo’s 21.73. So the peer picture is balanced: returns are competitive, but valuation is still on the richer side versus several hospital peers.

Why Investors Are Watching MEDANTA

• The stock fell 2.52% to Rs 1,431.90 in a Large Cap healthcare name.
• It opened at the session high of Rs 1,478.95 and later moved down to Rs 1,430.
• The stock is trading near the 50-day moving average of Rs 1,437.69 and above the 200-day moving average of Rs 1,241.98.
• P/E of 71.01 and P/B of 9.61 keep valuation under focus.
• ROE of 15.12% and ROCE of 19.38% remain above industry medians.

About MEDANTA

Global Health operates in the Healthcare sector under Hospital & Healthcare Services. Based on the supplied classification data, it is part of a closely tracked listed hospital universe where investors often compare companies on profitability, valuation and market-cap scale. That context is important whenever MEDANTA Share Price records a notable daily move.

Track MEDANTA Share Price on Univest

UseGlobal Health (MEDANTA) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.

Readers following MEDANTA Share Price can use Univest to track live price changes, valuation ratios, market capitalisation and peer context. That can be useful when a stock appears in market news without a confirmed company-specific trigger in the available data.

Frequently Asked Questions

Why is MEDANTA Share Price falling today?

Ans. The data confirms that the stock is down 2.52% to Rs 1,431.90 from the previous close of Rs 1,468.85. However, the supplied dataset does not establish a company-specific reason for the move.

What is the MEDANTA Share Price Today?

Ans. MEDANTA Share Price Today is Rs 1,431.90 as of 07 September 2026 at 11:23:24 AM IST, down Rs 36.95 on the day. The previous close was Rs 1,468.85. The stock moved 2.52% lower during the session.

What is Global Health's market capitalisation?

Ans. Global Health has a market capitalisation of Rs 39,493.23 crore and is classified as a Large Cap company. The company operates in the Healthcare sector. Its P/E ratio is 71.01x.

Is MEDANTA expensive compared with its industry benchmark?

Ans. On the supplied numbers, the stock trades at a P/E of 71.01, above the same-industry median of 46.45, and a P/B of 9.61, above the industry median of 3.35. The stock belongs to the Healthcare sector.

How does Global Health compare with Apollo, Max and Fortis?

Ans. Its P/E of 71.01 is above Apollo’s 59.66, Max’s 65.8 and Fortis’s 65.56. Its ROCE of 19.38% is below Apollo’s 21.73 but above Max’s 14.97 and Fortis’s 14.07. Comparable listed companies include Apollo Hospitals Enterprise, MANIPAL HEALTH ENTERPRI L, Max.

What should investors watch next?

Ans. Investors may watch whether the stock stabilises near current levels, how it behaves around the 50-day moving average of Rs 1,437.69, and whether valuation discussion versus peers remains a key market theme.